Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiation Therapy Sandwiched Between Paclitaxel and Carboplatin in UPSC
NCT00231868Phase 2Completed
- Sponsor
- Montefiore Medical Center
- Start
- Dec 2001
- Primary completion
- Jul 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel and carboplatin in uterine papillary serous carcinoma (UPSC), sponsored by Montefiore Medical Center. Primary endpoint: Toxicity and Tolerability at 7 years. Started Dec 2001; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
uterine papillary serous carcinoma (UPSC)
Beyond the preview
Go deeper on NCT00231868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231868.